LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses.

Sanchez David, Raul Y; Combredet, Chantal; Najburg, Valérie; Millot, Gael A; Beauclair, Guillaume; Schwikowski, Benno; Léger, Thibaut; Camadro, Jean-Michel; Jacob, Yves; Bellalou, Jacques; Jouvenet, Nolwenn; Tangy, Frédéric; Komarova, Anastassia V

The retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) RIG-I, MDA5, and LGP2 stimulate inflammatory and antiviral responses by sensing nonself RNA molecules produced during viral replication. Here, we investigated how LGP2 regulates the RIG-I- and MDA5-dependent induction of type I interferon (IFN) signaling and showed that LGP2 interacted with different components of the RNA-silencing machinery. We identified a direct protein-protein interaction between LGP2 and the IFN-inducible, double-stranded RNA binding protein PACT. The LGP2-PACT interaction was mediated by the regulatory C-terminal domain of LGP2 and was necessary for inhibiting RIG-I-dependent responses and for amplifying MDA5-dependent responses. We described a point mutation within LGP2 that disrupted the LGP2-PACT interaction and led to the loss of LGP2-mediated regulation of RIG-I and MDA5 signaling. These results suggest a model in which the LGP2-PACT interaction regulates the inflammatory responses mediated by RIG-I and MDA5 and enables the cellular RNA-silencing machinery to coordinate with the innate immune response.